Due to the relatively low number of detected down-regulated genes, only one pathway was found to be significant, and it contained genes overexpressed at the start of the training schedule (T1): hypertrophic cardiomyopathy (HCM) pathway (CACNB1, TPM1, TPM2, TTN). The gene discussed is TPM2; the disease is hypertrophic cardiomyopathy.